The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Vivo and In Vitro ADME Market Research Report 2025

Global In Vivo and In Vitro ADME Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1986730

No of Pages : 100

Ask Your Query
Synopsis
In the early stages of drug discovery, it is important to understand the key physicochemical properties and structural motifs that drive the efficacy and safety profile of a compound candidate. In vitro and in vivo ADME is used to identify the attributes of absorption, distribution, metabolism, and excretion. ADME assays are critical in gaining insight into metabolism and potential drug interactions.
The global In Vivo and In Vitro ADME market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for In Vivo and In Vitro ADME is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for In Vivo and In Vitro ADME is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for In Vivo and In Vitro ADME in Biopharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of In Vivo and In Vitro ADME include Charles River, Labcorp, ICON, Syneos Health, Envigo, Curia, Evotec, Bioduro-Sundia and Lonza, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In Vivo and In Vitro ADME, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In Vivo and In Vitro ADME.
Report Scope
The In Vivo and In Vitro ADME market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global In Vivo and In Vitro ADME market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In Vivo and In Vitro ADME companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Labcorp
ICON
Syneos Health
Envigo
Curia
Evotec
Bioduro-Sundia
Lonza
WuXi AppTec
IQVIA
Tecan Group
Pharmaron
Shanghai Medicilon
ChemPartner
Joinn Laboratories
RTI International
Eurofins Scientific
Aragen Life Sciences
Sai Life Sciences
Segment by Type
Small Molecules
Biologics
Segment by Application
Biopharmaceutical Companies
Government and Academic Institutes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In Vivo and In Vitro ADME companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vivo and In Vitro ADME Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Small Molecules
1.2.3 Biologics
1.3 Market by Application
1.3.1 Global In Vivo and In Vitro ADME Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Government and Academic Institutes
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vivo and In Vitro ADME Market Perspective (2019-2030)
2.2 In Vivo and In Vitro ADME Growth Trends by Region
2.2.1 Global In Vivo and In Vitro ADME Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 In Vivo and In Vitro ADME Historic Market Size by Region (2019-2024)
2.2.3 In Vivo and In Vitro ADME Forecasted Market Size by Region (2025-2030)
2.3 In Vivo and In Vitro ADME Market Dynamics
2.3.1 In Vivo and In Vitro ADME Industry Trends
2.3.2 In Vivo and In Vitro ADME Market Drivers
2.3.3 In Vivo and In Vitro ADME Market Challenges
2.3.4 In Vivo and In Vitro ADME Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vivo and In Vitro ADME Players by Revenue
3.1.1 Global Top In Vivo and In Vitro ADME Players by Revenue (2019-2024)
3.1.2 Global In Vivo and In Vitro ADME Revenue Market Share by Players (2019-2024)
3.2 Global In Vivo and In Vitro ADME Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In Vivo and In Vitro ADME Revenue
3.4 Global In Vivo and In Vitro ADME Market Concentration Ratio
3.4.1 Global In Vivo and In Vitro ADME Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vivo and In Vitro ADME Revenue in 2023
3.5 In Vivo and In Vitro ADME Key Players Head office and Area Served
3.6 Key Players In Vivo and In Vitro ADME Product Solution and Service
3.7 Date of Enter into In Vivo and In Vitro ADME Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vivo and In Vitro ADME Breakdown Data by Type
4.1 Global In Vivo and In Vitro ADME Historic Market Size by Type (2019-2024)
4.2 Global In Vivo and In Vitro ADME Forecasted Market Size by Type (2025-2030)
5 In Vivo and In Vitro ADME Breakdown Data by Application
5.1 Global In Vivo and In Vitro ADME Historic Market Size by Application (2019-2024)
5.2 Global In Vivo and In Vitro ADME Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America In Vivo and In Vitro ADME Market Size (2019-2030)
6.2 North America In Vivo and In Vitro ADME Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America In Vivo and In Vitro ADME Market Size by Country (2019-2024)
6.4 North America In Vivo and In Vitro ADME Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vivo and In Vitro ADME Market Size (2019-2030)
7.2 Europe In Vivo and In Vitro ADME Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe In Vivo and In Vitro ADME Market Size by Country (2019-2024)
7.4 Europe In Vivo and In Vitro ADME Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In Vivo and In Vitro ADME Market Size (2019-2030)
8.2 Asia-Pacific In Vivo and In Vitro ADME Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2019-2024)
8.4 Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In Vivo and In Vitro ADME Market Size (2019-2030)
9.2 Latin America In Vivo and In Vitro ADME Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America In Vivo and In Vitro ADME Market Size by Country (2019-2024)
9.4 Latin America In Vivo and In Vitro ADME Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vivo and In Vitro ADME Market Size (2019-2030)
10.2 Middle East & Africa In Vivo and In Vitro ADME Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2019-2024)
10.4 Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Detail
11.1.2 Charles River Business Overview
11.1.3 Charles River In Vivo and In Vitro ADME Introduction
11.1.4 Charles River Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.1.5 Charles River Recent Development
11.2 Labcorp
11.2.1 Labcorp Company Detail
11.2.2 Labcorp Business Overview
11.2.3 Labcorp In Vivo and In Vitro ADME Introduction
11.2.4 Labcorp Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.2.5 Labcorp Recent Development
11.3 ICON
11.3.1 ICON Company Detail
11.3.2 ICON Business Overview
11.3.3 ICON In Vivo and In Vitro ADME Introduction
11.3.4 ICON Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.3.5 ICON Recent Development
11.4 Syneos Health
11.4.1 Syneos Health Company Detail
11.4.2 Syneos Health Business Overview
11.4.3 Syneos Health In Vivo and In Vitro ADME Introduction
11.4.4 Syneos Health Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.4.5 Syneos Health Recent Development
11.5 Envigo
11.5.1 Envigo Company Detail
11.5.2 Envigo Business Overview
11.5.3 Envigo In Vivo and In Vitro ADME Introduction
11.5.4 Envigo Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.5.5 Envigo Recent Development
11.6 Curia
11.6.1 Curia Company Detail
11.6.2 Curia Business Overview
11.6.3 Curia In Vivo and In Vitro ADME Introduction
11.6.4 Curia Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.6.5 Curia Recent Development
11.7 Evotec
11.7.1 Evotec Company Detail
11.7.2 Evotec Business Overview
11.7.3 Evotec In Vivo and In Vitro ADME Introduction
11.7.4 Evotec Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.7.5 Evotec Recent Development
11.8 Bioduro-Sundia
11.8.1 Bioduro-Sundia Company Detail
11.8.2 Bioduro-Sundia Business Overview
11.8.3 Bioduro-Sundia In Vivo and In Vitro ADME Introduction
11.8.4 Bioduro-Sundia Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.8.5 Bioduro-Sundia Recent Development
11.9 Lonza
11.9.1 Lonza Company Detail
11.9.2 Lonza Business Overview
11.9.3 Lonza In Vivo and In Vitro ADME Introduction
11.9.4 Lonza Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.9.5 Lonza Recent Development
11.10 WuXi AppTec
11.10.1 WuXi AppTec Company Detail
11.10.2 WuXi AppTec Business Overview
11.10.3 WuXi AppTec In Vivo and In Vitro ADME Introduction
11.10.4 WuXi AppTec Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.10.5 WuXi AppTec Recent Development
11.11 IQVIA
11.11.1 IQVIA Company Detail
11.11.2 IQVIA Business Overview
11.11.3 IQVIA In Vivo and In Vitro ADME Introduction
11.11.4 IQVIA Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.11.5 IQVIA Recent Development
11.12 Tecan Group
11.12.1 Tecan Group Company Detail
11.12.2 Tecan Group Business Overview
11.12.3 Tecan Group In Vivo and In Vitro ADME Introduction
11.12.4 Tecan Group Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.12.5 Tecan Group Recent Development
11.13 Pharmaron
11.13.1 Pharmaron Company Detail
11.13.2 Pharmaron Business Overview
11.13.3 Pharmaron In Vivo and In Vitro ADME Introduction
11.13.4 Pharmaron Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.13.5 Pharmaron Recent Development
11.14 Shanghai Medicilon
11.14.1 Shanghai Medicilon Company Detail
11.14.2 Shanghai Medicilon Business Overview
11.14.3 Shanghai Medicilon In Vivo and In Vitro ADME Introduction
11.14.4 Shanghai Medicilon Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.14.5 Shanghai Medicilon Recent Development
11.15 ChemPartner
11.15.1 ChemPartner Company Detail
11.15.2 ChemPartner Business Overview
11.15.3 ChemPartner In Vivo and In Vitro ADME Introduction
11.15.4 ChemPartner Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.15.5 ChemPartner Recent Development
11.16 Joinn Laboratories
11.16.1 Joinn Laboratories Company Detail
11.16.2 Joinn Laboratories Business Overview
11.16.3 Joinn Laboratories In Vivo and In Vitro ADME Introduction
11.16.4 Joinn Laboratories Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.16.5 Joinn Laboratories Recent Development
11.17 RTI International
11.17.1 RTI International Company Detail
11.17.2 RTI International Business Overview
11.17.3 RTI International In Vivo and In Vitro ADME Introduction
11.17.4 RTI International Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.17.5 RTI International Recent Development
11.18 Eurofins Scientific
11.18.1 Eurofins Scientific Company Detail
11.18.2 Eurofins Scientific Business Overview
11.18.3 Eurofins Scientific In Vivo and In Vitro ADME Introduction
11.18.4 Eurofins Scientific Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.18.5 Eurofins Scientific Recent Development
11.19 Aragen Life Sciences
11.19.1 Aragen Life Sciences Company Detail
11.19.2 Aragen Life Sciences Business Overview
11.19.3 Aragen Life Sciences In Vivo and In Vitro ADME Introduction
11.19.4 Aragen Life Sciences Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.19.5 Aragen Life Sciences Recent Development
11.20 Sai Life Sciences
11.20.1 Sai Life Sciences Company Detail
11.20.2 Sai Life Sciences Business Overview
11.20.3 Sai Life Sciences In Vivo and In Vitro ADME Introduction
11.20.4 Sai Life Sciences Revenue in In Vivo and In Vitro ADME Business (2019-2024)
11.20.5 Sai Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global In Vivo and In Vitro ADME Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Small Molecules
Table 3. Key Players of Biologics
Table 4. Global In Vivo and In Vitro ADME Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global In Vivo and In Vitro ADME Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global In Vivo and In Vitro ADME Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global In Vivo and In Vitro ADME Market Share by Region (2019-2024)
Table 8. Global In Vivo and In Vitro ADME Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global In Vivo and In Vitro ADME Market Share by Region (2025-2030)
Table 10. In Vivo and In Vitro ADME Market Trends
Table 11. In Vivo and In Vitro ADME Market Drivers
Table 12. In Vivo and In Vitro ADME Market Challenges
Table 13. In Vivo and In Vitro ADME Market Restraints
Table 14. Global In Vivo and In Vitro ADME Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global In Vivo and In Vitro ADME Market Share by Players (2019-2024)
Table 16. Global Top In Vivo and In Vitro ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro ADME as of 2023)
Table 17. Ranking of Global Top In Vivo and In Vitro ADME Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by In Vivo and In Vitro ADME Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vivo and In Vitro ADME Product Solution and Service
Table 21. Date of Enter into In Vivo and In Vitro ADME Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In Vivo and In Vitro ADME Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global In Vivo and In Vitro ADME Revenue Market Share by Type (2019-2024)
Table 25. Global In Vivo and In Vitro ADME Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global In Vivo and In Vitro ADME Revenue Market Share by Type (2025-2030)
Table 27. Global In Vivo and In Vitro ADME Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global In Vivo and In Vitro ADME Revenue Market Share by Application (2019-2024)
Table 29. Global In Vivo and In Vitro ADME Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global In Vivo and In Vitro ADME Revenue Market Share by Application (2025-2030)
Table 31. North America In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America In Vivo and In Vitro ADME Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America In Vivo and In Vitro ADME Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe In Vivo and In Vitro ADME Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe In Vivo and In Vitro ADME Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific In Vivo and In Vitro ADME Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific In Vivo and In Vitro ADME Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America In Vivo and In Vitro ADME Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America In Vivo and In Vitro ADME Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa In Vivo and In Vitro ADME Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa In Vivo and In Vitro ADME Market Size by Country (2025-2030) & (US$ Million)
Table 46. Charles River Company Detail
Table 47. Charles River Business Overview
Table 48. Charles River In Vivo and In Vitro ADME Product
Table 49. Charles River Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 50. Charles River Recent Development
Table 51. Labcorp Company Detail
Table 52. Labcorp Business Overview
Table 53. Labcorp In Vivo and In Vitro ADME Product
Table 54. Labcorp Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 55. Labcorp Recent Development
Table 56. ICON Company Detail
Table 57. ICON Business Overview
Table 58. ICON In Vivo and In Vitro ADME Product
Table 59. ICON Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 60. ICON Recent Development
Table 61. Syneos Health Company Detail
Table 62. Syneos Health Business Overview
Table 63. Syneos Health In Vivo and In Vitro ADME Product
Table 64. Syneos Health Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 65. Syneos Health Recent Development
Table 66. Envigo Company Detail
Table 67. Envigo Business Overview
Table 68. Envigo In Vivo and In Vitro ADME Product
Table 69. Envigo Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 70. Envigo Recent Development
Table 71. Curia Company Detail
Table 72. Curia Business Overview
Table 73. Curia In Vivo and In Vitro ADME Product
Table 74. Curia Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 75. Curia Recent Development
Table 76. Evotec Company Detail
Table 77. Evotec Business Overview
Table 78. Evotec In Vivo and In Vitro ADME Product
Table 79. Evotec Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 80. Evotec Recent Development
Table 81. Bioduro-Sundia Company Detail
Table 82. Bioduro-Sundia Business Overview
Table 83. Bioduro-Sundia In Vivo and In Vitro ADME Product
Table 84. Bioduro-Sundia Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 85. Bioduro-Sundia Recent Development
Table 86. Lonza Company Detail
Table 87. Lonza Business Overview
Table 88. Lonza In Vivo and In Vitro ADME Product
Table 89. Lonza Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 90. Lonza Recent Development
Table 91. WuXi AppTec Company Detail
Table 92. WuXi AppTec Business Overview
Table 93. WuXi AppTec In Vivo and In Vitro ADME Product
Table 94. WuXi AppTec Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 95. WuXi AppTec Recent Development
Table 96. IQVIA Company Detail
Table 97. IQVIA Business Overview
Table 98. IQVIA In Vivo and In Vitro ADME Product
Table 99. IQVIA Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 100. IQVIA Recent Development
Table 101. Tecan Group Company Detail
Table 102. Tecan Group Business Overview
Table 103. Tecan Group In Vivo and In Vitro ADME Product
Table 104. Tecan Group Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 105. Tecan Group Recent Development
Table 106. Pharmaron Company Detail
Table 107. Pharmaron Business Overview
Table 108. Pharmaron In Vivo and In Vitro ADME Product
Table 109. Pharmaron Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 110. Pharmaron Recent Development
Table 111. Shanghai Medicilon Company Detail
Table 112. Shanghai Medicilon Business Overview
Table 113. Shanghai Medicilon In Vivo and In Vitro ADME Product
Table 114. Shanghai Medicilon Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 115. Shanghai Medicilon Recent Development
Table 116. ChemPartner Company Detail
Table 117. ChemPartner Business Overview
Table 118. ChemPartner In Vivo and In Vitro ADME Product
Table 119. ChemPartner Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 120. ChemPartner Recent Development
Table 121. Joinn Laboratories Company Detail
Table 122. Joinn Laboratories Business Overview
Table 123. Joinn Laboratories In Vivo and In Vitro ADME Product
Table 124. Joinn Laboratories Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 125. Joinn Laboratories Recent Development
Table 126. RTI International Company Detail
Table 127. RTI International Business Overview
Table 128. RTI International In Vivo and In Vitro ADME Product
Table 129. RTI International Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 130. RTI International Recent Development
Table 131. Eurofins Scientific Company Detail
Table 132. Eurofins Scientific Business Overview
Table 133. Eurofins Scientific In Vivo and In Vitro ADME Product
Table 134. Eurofins Scientific Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 135. Eurofins Scientific Recent Development
Table 136. Aragen Life Sciences Company Detail
Table 137. Aragen Life Sciences Business Overview
Table 138. Aragen Life Sciences In Vivo and In Vitro ADME Product
Table 139. Aragen Life Sciences Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 140. Aragen Life Sciences Recent Development
Table 141. Sai Life Sciences Company Detail
Table 142. Sai Life Sciences Business Overview
Table 143. Sai Life Sciences In Vivo and In Vitro ADME Product
Table 144. Sai Life Sciences Revenue in In Vivo and In Vitro ADME Business (2019-2024) & (US$ Million)
Table 145. Sai Life Sciences Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In Vivo and In Vitro ADME Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global In Vivo and In Vitro ADME Market Share by Type: 2023 VS 2030
Figure 3. Small Molecules Features
Figure 4. Biologics Features
Figure 5. Global In Vivo and In Vitro ADME Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global In Vivo and In Vitro ADME Market Share by Application: 2023 VS 2030
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Government and Academic Institutes Case Studies
Figure 9. Others Case Studies
Figure 10. In Vivo and In Vitro ADME Report Years Considered
Figure 11. Global In Vivo and In Vitro ADME Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global In Vivo and In Vitro ADME Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global In Vivo and In Vitro ADME Market Share by Region: 2023 VS 2030
Figure 14. Global In Vivo and In Vitro ADME Market Share by Players in 2023
Figure 15. Global Top In Vivo and In Vitro ADME Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In Vivo and In Vitro ADME as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by In Vivo and In Vitro ADME Revenue in 2023
Figure 17. North America In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America In Vivo and In Vitro ADME Market Share by Country (2019-2030)
Figure 19. United States In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe In Vivo and In Vitro ADME Market Share by Country (2019-2030)
Figure 23. Germany In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific In Vivo and In Vitro ADME Market Share by Region (2019-2030)
Figure 31. China In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America In Vivo and In Vitro ADME Market Share by Country (2019-2030)
Figure 39. Mexico In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa In Vivo and In Vitro ADME Market Share by Country (2019-2030)
Figure 43. Turkey In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia In Vivo and In Vitro ADME Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Charles River Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 46. Labcorp Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 47. ICON Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 48. Syneos Health Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 49. Envigo Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 50. Curia Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 51. Evotec Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 52. Bioduro-Sundia Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 53. Lonza Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 54. WuXi AppTec Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 55. IQVIA Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 56. Tecan Group Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 57. Pharmaron Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 58. Shanghai Medicilon Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 59. ChemPartner Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 60. Joinn Laboratories Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 61. RTI International Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 62. Eurofins Scientific Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 63. Aragen Life Sciences Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 64. Sai Life Sciences Revenue Growth Rate in In Vivo and In Vitro ADME Business (2019-2024)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock